Subject
Now showing items 1-2 of 2
-
The nature of relapse in schizophrenia
(BioMed Cenral, 2013-02)Background Multiple relapses characterise the course of illness in most patients with schizophrenia, yet the nature of these episodes has not been extensively researched and clinicians may not always be aware of important ... -
Placebo controls in clinical trials : concerns about use in relapse prevention studies in schizophrenia
(BMJ Publishing Group, 2016)ENGLISH SUMMARY : The use of placebos in clinical trials has major policy implications for ethical conduct across all of medicine and is relevant to clinicians, patients, drug development, and regulatory agencies. This ...